Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438849 · ClinicalTrials.gov registry record
Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans
A clinical trial of Urinary Incontinence, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- 2,500
- Enrollment target
- 2
- Study locations
NCT05438849 is a study of Urinary Incontinence that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 2,500 participants, above the 210-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (1090% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT05438849, a study of Urinary Incontinence, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The PURSUIT project aims to improve access to evidence-based nonsurgical UI treatment for women Veterans in the Southeast region of the United States using the most effective remote delivery modality. Using cluster randomization, the study will compare two models at the practice level: (1) the use of a practice facilitation toolkit with a mHealth UI modality alone and (2) the practice facilitation toolkit with a mHealth UI model combined with education on clinical pathways for consultation. Patient level outcomes related to UI symptom improvement will be compared. Patient and provider perceptions of factors that could influence future remote UI treatment scalability will also be assessed. All primary care practices will receive practice facilitation with a PURSUIT toolkit that includes (1) 1-2 visits with a practice facilitator; (2) mobile-health or mHealth application training (MAT); 3) online resource hub; and (4) health information technology (HIT) assistance. PURSUIT's future goal is to disseminate the most effective modality for delivering nonsurgical UI treatment for women Veterans nationally within the VHA.
Conditions Studied
Interventions
- BEHAVIORAL Mobile Health Application focused on behavioral treatments to treat urinary incontinence
- COMBINATION_PRODUCT Practice Facilitation
Study Locations (2)
Alabama
- Birmingham VA Healthcare System - Birmingham
Georgia
- Atlanta VA Health Care System - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05438849
The ClinicalTrials.gov registry entry for NCT05438849 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 210-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (1090% higher). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Mobile Health Application focused on behavioral treatments to treat urinary incontinence is the first listed.
NCT05438849 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Georgia.
Frequently Asked Questions
What is clinical trial NCT05438849 about?
NCT05438849 is a clinical study titled "Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans". The PURSUIT project aims to improve access to evidence-based nonsurgical UI treatment for women Veterans in the Southeast region of the United States using the most effective remote delivery modality. Using cluster randomization, the study will compare two models at the practice level: (1) the use o...
What is the current status of trial NCT05438849?
This trial is currently active not recruiting. The enrollment target is 2,500 participants. The study started on 2022-11-01. Estimated completion is 2026-06.
What conditions does trial NCT05438849 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT05438849?
The interventions under investigation include: Mobile Health Application focused on behavioral treatments to treat urinary incontinence (BEHAVIORAL), Practice Facilitation (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05438849?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438849 being conducted?
This trial has 2 study locations across Alabama, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.